Literature DB >> 8431972

Cytotoxicity, DNA cross-linking, and DNA single-strand breaks induced by cyclophosphamide in a rat leukemia in vivo.

J Y Wang1, G Prorok, W P Vaughan.   

Abstract

A study of cyclophosphamide (CP)-induced DNA damage and repair occurring in vivo was conducted in the brown Norway rat myelocytic leukemia (BNML) model. DNA single-strand breaks (SSB), DNA-DNA interstrand cross-links (DIC), DNA-protein cross-links (DPC), and DNA double-strand breaks (DSB) were measured by alkaline and neutral elution. After i.p. injection of 50 mg/kg CP, DIC were detectable at 1 h and peaked at 8 h. DPC were detectable at 2 h and peaked at 6 h. Both DIC and DPC persisted at a relatively high level until 28 h. Dose-response curves for both DIC and DPC were determined at 4 h after CP injection over the dose range of 25-150 mg/kg. These doses ranged from the minimally effective dose to doses curative for rats bearing this leukemia (1- to 9-log kill of leukemia cells). No SSB or DSB was observed at 4 h after CP injection over the dose range of 15-250 mg/kg, but a low level of SSB was observed at 18-28 h after CP treatment. These data suggest that the cytotoxic effect of CP in vivo is mediated mostly by DIC and DPC. SSB appearing late after CP injection in vivo may be a reflection of repair of DIC and DPC and an indication of the optimal timing for administration of DNA-repair inhibitors. This observation is of interest since our earlier work demonstrated that hydroxyurea can potentiate the therapeutic benefit of CP in this model when it is given over the 4-day period immediately after CP treatment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8431972     DOI: 10.1007/bf00686152

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  39 in total

1.  Protection by WR-3689 against gamma-ray-induced intestinal damage: comparative effect on clonogenic cell survival, mouse survival, and DNA damage.

Authors:  D Murray; E M Altschuler; N Hunter; L Milas
Journal:  Radiat Res       Date:  1989-11       Impact factor: 2.841

2.  32P-postlabeling analysis of binding of the cyclophosphamide metabolite, acrolein, to DNA.

Authors:  A E Maccubbin; L Caballes; F Scappaticci; R F Struck; H L Gurtoo
Journal:  Cancer Commun       Date:  1990

3.  DNA damage and repair in patients receiving high-dose cyclophosphamide and radiation.

Authors:  C D Ford; C T Warnick
Journal:  NCI Monogr       Date:  1988

4.  DNA strand breaks in human leukocytes induced by chemotherapy and total body irradiation.

Authors:  C Franssen; P Boekema; T De Witte; J Wessels; A Van der Kogel; C Haanen
Journal:  Leuk Res       Date:  1990       Impact factor: 3.156

5.  Alkaline elution of rat testicular DNA: detection of DNA cross-links after in vivo treatment with chemical mutagens.

Authors:  J A Skare; K R Schrotel
Journal:  Mutat Res       Date:  1984-08       Impact factor: 2.433

6.  DNA-binding products of nornitrogen mustard, a metabolite of cyclophosphamide.

Authors:  K Hemminki
Journal:  Chem Biol Interact       Date:  1987-01       Impact factor: 5.192

7.  Effect of cyclophosphamide on the immature rat ovary.

Authors:  K M Ataya; F A Valeriote; A J Ramahi-Ataya
Journal:  Cancer Res       Date:  1989-04-01       Impact factor: 12.701

8.  Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells.

Authors:  T R Crook; R L Souhami; A E McLean
Journal:  Cancer Res       Date:  1986-10       Impact factor: 12.701

9.  In vitro colony formation of transplantable rat leukemias in comparison with human acute myeloid leukemia.

Authors:  D W van Bekkum; P van Oosterom; K A Dicke
Journal:  Cancer Res       Date:  1976-03       Impact factor: 12.701

10.  N-(2-hydroxyethyl)-N-[2-(7-guaninyl)ethyl]amine, the putative major DNA adduct of cyclophosphamide in vitro and in vivo in the rat.

Authors:  A J Benson; C N Martin; R C Garner
Journal:  Biochem Pharmacol       Date:  1988-08-01       Impact factor: 5.858

View more
  3 in total

1.  Cyclophosphamide promotes engraftment of gene-modified cells in a mouse model of Fanconi anemia without causing cytogenetic abnormalities.

Authors:  Jennifer E Adair; Xin Zhao; Sylvia Chien; Min Fang; Martin E Wohlfahrt; Grant D Trobridge; Jason A Taylor; Brian C Beard; Hans-Peter Kiem; Pamela S Becker
Journal:  J Mol Med (Berl)       Date:  2012-06-03       Impact factor: 4.599

2.  Lipocalin2 Induced by Bacterial Flagellin Protects Mice against Cyclophosphamide Mediated Neutropenic Sepsis.

Authors:  Daejin Lim; Hee Kyung Kim; Jae-Ho Jeong; Yoon Seok Jung; Shee Eun Lee; Hee-Chang Jang; Sook-In Jung; Hueng-Sik Choi; Joon Haeng Rhee; Sung-Gwon Lee; Chungoo Park; Miryoung Song; Hyon E Choy
Journal:  Microorganisms       Date:  2020-04-29

Review 3.  Potential of helper-dependent Adenoviral vectors in CRISPR-cas9-mediated lung gene therapy.

Authors:  Ranmal Avinash Bandara; Ziyan Rachel Chen; Jim Hu
Journal:  Cell Biosci       Date:  2021-07-23       Impact factor: 7.133

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.